Marisa Zammit asks Mike about his background, how Mike came to join Imagion and how Mike thinks Imagion’s technology could transform the imaging industry.
Positive independent review sets priority path to market for MagSense® Technology
Highlights Blinded review by panel of expert breast radiologists corroborates potential for MagSense® nanoparticle technology to detect tumour cells in lymph nodes by Magnetic Resonance